Atomo Diagnostics Limited (ASX: AT1)
Australia
· Delayed Price · Currency is AUD 0.0190
0.00 (0.00%)
Dec 20, 2024, 3:11 PM AEST
Atomo Diagnostics Revenue
In the fiscal year ending June 30, 2024, Atomo Diagnostics had annual revenue of 4.09M AUD with 60.65% growth. Atomo Diagnostics had revenue of 2.16M in the half year ending June 30, 2024, a decrease of -69.07%.
Revenue
4.09M
Revenue Growth
+60.65%
P/S Ratio
2.95
Revenue / Employee
48.08K
Employees
85
Market Cap
12.14M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.74B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Telix Pharmaceuticals Limited | 645.68M |
| Ramsay Health Care Limited | 16.66B |